| 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the … M Humbert, G Kovacs, MM Hoeper, R Badagliacca, RMF Berger, M Brida, ... European heart journal 43 (38), 3618-3731, 2022 | 2396 | 2022 |
| Definitions and diagnosis of pulmonary hypertension MM Hoeper, HJ Bogaard, R Condliffe, R Frantz, D Khanna, M Kurzyna, ... Journal of the American College of Cardiology 62 (25S), D42-D50, 2013 | 2236 | 2013 |
| Riociguat for the treatment of chronic thromboembolic pulmonary hypertension HA Ghofrani, AM D'Armini, F Grimminger, MM Hoeper, P Jansa, NH Kim, ... New England Journal of Medicine 369 (4), 319-329, 2013 | 1608 | 2013 |
| Mechanisms of disease: pulmonary arterial hypertension RT Schermuly, HA Ghofrani, MR Wilkins, F Grimminger Nature Reviews Cardiology 8 (8), 443-455, 2011 | 834 | 2011 |
| Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies SL Archer, EK Weir, MR Wilkins Circulation 121 (18), 2045-2066, 2010 | 644 | 2010 |
| Sildenafil inhibits hypoxia-induced pulmonary hypertension L Zhao, NA Mason, NW Morrell, B Kojonazarov, A Sadykov, A Maripov, ... Circulation 104 (4), 424-428, 2001 | 635 | 2001 |
| Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general … I Tzoulaki, M Molokhia, V Curcin, MP Little, CJ Millett, A Ng, RI Hughes, ... Bmj 339, 2009 | 576 | 2009 |
| Sildenafil versus endothelin receptor antagonist for pulmonary hypertension (SERAPH) study MR Wilkins, GA Paul, JW Strange, N Tunariu, W Gin-Sing, WA Banya, ... American journal of respiratory and critical care medicine 171 (11), 1292-1297, 2005 | 511 | 2005 |
| Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells J Wharton, JW Strange, GMO Møller, EJ Growcott, X Ren, AP Franklyn, ... American journal of respiratory and critical care medicine 172 (1), 105-113, 2005 | 482 | 2005 |
| The natriuretic-peptide family MR Wilkins, J Redondo, LA Brown The Lancet 349 (9061), 1307-1310, 1997 | 421 | 1997 |
| Whole-genome sequencing of patients with rare diseases in a national health system E Turro, WJ Astle, K Megy, S Gräf, D Greene, O Shamardina, HL Allen, ... Nature 583 (7814), 96-102, 2020 | 413 | 2020 |
| Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: a long-term extension study (CHEST-2) G Simonneau, AM D’Armini, HA Ghofrani, F Grimminger, MM Hoeper, ... European Respiratory Journal 45 (5), 1293-1302, 2015 | 364 | 2015 |
| Identification of rare sequence variation underlying heritable pulmonary arterial hypertension S Gräf, M Haimel, M Bleda, C Hadinnapola, L Southgate, W Li, J Hodgson, ... Nature communications 9 (1), 1416, 2018 | 354 | 2018 |
| Phosphodiesterase type 5 as a target for the treatment of hypoxia-induced pulmonary hypertension A Sebkhi, JW Strange, SC Phillips, J Wharton, MR Wilkins Circulation 107 (25), 3230-3235, 2003 | 310 | 2003 |
| Bosentan decreases the plasma concentration of sildenafil when coprescribed in pulmonary hypertension GA Paul, JSR Gibbs, AR Boobis, A Abbas, MR Wilkins British journal of clinical pharmacology 60 (1), 107-112, 2005 | 293 | 2005 |
| Iron deficiency and raised hepcidin in idiopathic pulmonary arterial hypertension: clinical prevalence, outcomes, and mechanistic insights CJ Rhodes, LS Howard, M Busbridge, D Ashby, E Kondili, JSR Gibbs, ... Journal of the American College of Cardiology 58 (3), 300-309, 2011 | 292 | 2011 |
| Circulating endothelial progenitor cells in patients with Eisenmenger syndrome and idiopathic pulmonary arterial hypertension GP Diller, S van Eijl, DO Okonko, LS Howard, O Ali, T Thum, SJ Wort, ... Circulation 117 (23), 3020-3030, 2008 | 281 | 2008 |
| Histone deacetylation inhibition in pulmonary hypertension: therapeutic potential of valproic acid and suberoylanilide hydroxamic acid L Zhao, CN Chen, N Hajji, E Oliver, E Cotroneo, J Wharton, D Wang, M Li, ... Circulation 126 (4), 455-467, 2012 | 276 | 2012 |
| Inhibition of pyruvate dehydrogenase kinase improves pulmonary arterial hypertension in genetically susceptible patients ED Michelakis, V Gurtu, L Webster, G Barnes, G Watson, L Howard, ... Science translational medicine 9 (413), eaao4583, 2017 | 263 | 2017 |
| Deep-learning cardiac motion analysis for human survival prediction GA Bello, TJW Dawes, J Duan, C Biffi, A De Marvao, LSGE Howard, ... Nature machine intelligence 1 (2), 95-104, 2019 | 240 | 2019 |
